2Johnston WW, SZPak CA, Lotlich SC, et al . Use of a monoclonal antibody (B72.3)as an Immunocytochemical adiunct to diagnosis of adencarcinma in human effusions [J]. Cancer Res.1985.45.(4).894-900.
3Guzman J. Bross KJ, Wurtemberger G, el al. Immunocytology in malignant plearal mesothelioma, expression of tumor markers and distribution of Lymphocyte Subsets [J]. Chest, 1989.95 (3), 590-595.
4Brown RW. Rus h RA, wilson PA, et al. Muidple - marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcirtoma [J].hum Pathal.1993.24(4).347-354.
5Wick MR, Loy T, Mills SE, et at, Malignant eplthelioid mesothelioma Versus peripheral pulmonary adenocarcinoma:a histochemical ultralsrruetural and immunohistologic study of 103 cases [J]. Hum Pathol. 1990. 21 (5). 759.
6Ruitenbeek T, Gouw ASH. Immunoeytology of body cavity fluids,moc31 a monoclorml antibody discriminating betweenn, mesothelial and epithelial cells [J]. Arch Pathol Lab Med,1994. 118 (3): 265-269.
8Ohosh AK, Gatter KC, Dunaill MS, et al. Immuaohistochenlical staining of reactive mesothelium, mesothelioma,and lung carcinoma with a panel of monoclonal antibodies[J].,J Chin Pathol, 1987, 40 (1). 19- 25.
9Wirth PR, Legier J, Wright GL. et al lmmunohistochemieal evaluation of seven monoetonal antibodies for differentiation of pleural mesothelioma from lung adenoeercinoma [J]. Cancer.1991.67(2).655-662.
10Battifora H, Kopinski M, Distinction of mesothelioms from adenocarcinoma : an immunohistochemical approach [J]. Cancer.1985.55(11).1679-1685.
